Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Aquinox initiates phase III study of AQX-1125 for interstitial cystitis/bladder pain syndrome

Sep. 7, 2016

Nymox's fexapotide shows clinically meaningful benefits in BPH

Aug. 31, 2016

Nymox Pharmaceutical announces positive results on fexapotide phase III trial

Aug. 25, 2016

Aurinia reports promising findings from phase IIb study of voclosporin in active lupus nephritis

Aug. 16, 2016

Apricus expands Vitaros agreement with Ferring, terminates agreement with Sandoz

July 27, 2016

Resverlogix begins dosing in phase I study of apabetalone in severe renal impairment

July 22, 2016

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

July 7, 2016

Pfizer introduces AMPK activators

June 22, 2016

FDA approves Rayaldee for secondary hyperparathyroidism in CKD

June 21, 2016

Boehringer Ingelheim discloses aldosterone synthase inhibitors

June 20, 2016

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...